Sleep Profiler PSG2™ Cleared by FDA to Diagnose Sleep Apnea

CARLSBAD, Calif.–(BUSINESS WIRE)–#homesleeptest–Advanced Brain Monitoring, Inc. announces the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Sleep Profiler™, the most widely used, self-applied system for the assessment of overnight EEG in patients with insomnia or mood disorders, to be used in the diagnosis of sleep apnea. “Sleep Profiler PSG2 meets the requirements for unattended polysomnography, the most accurate method for in-home assessment of sleep-disordered breathing,” state
Source: BusinessWire-Primary

Sleep Profiler PSG2™ Cleared by FDA to Diagnose Sleep Apnea